SOUTH SAN FRANCISCO, Calif. (KGO) -- As the demand for new drugs is growing, it's challenging the biotech industry to re-think its approach to making them for clinical trials. South San Francisco's ...

Many diseases can be successfully treated in the simple environment of a cell culture dish, but to successfully treat real people, the drug agent has to take a journey through the infinitely more ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that new data were presented at the AD/PD 2025 International ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced a multi-year strategic research collaboration with NVIDIA that ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The CEO previously helped ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Genentech opens a 255,000-square-foot building on its South ...

After its founding in 1976, scientists at Genentech worked methodically toward the development of its first biotechnology product. It was nearly a decade later that the FDA approved Protropin, a ...

A piece of lab equipment is hoisted into place with the aid of a construction crane as Genentech works to update Cell Culture Plant 2 at their Vacaville facility on Thursday. The area of the plant was ...

Genentech recently launched Futurelab+, a $10 million expansion of its existing educational initiative to boost interest in students around career opportunities in the biotech sector. As part of ...

Genentech has begun operating a second cell-culture plant at its massive Vacaville manufacturing complex, following approval in April from the European Medicines Agency to produce an under-the-skin ...

Consumer-oriented genetic testing company 23andMe's up to $60 million partnership to provide Big Pharma company Genentech with access to information on about 3,000 Parkinson's patients illustrates the ...